GlassScriptPhysician profile
Bonnie Simpson
NPI 1699786038
$1,682.94
in general payments reported to CMS, 2019-2025
14 companies · $106 in 2025
The $106 reported for 2025 was less than what a typical Obstetrics & Gynecology (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Obstetrics & Gynecology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $166 · 2022: $571 · 2023: $668 · 2024: $172 · 2025: $106.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $779 · Education: $167.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $779.48 |
| Education | $166.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $623.66 | 2021-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $428.93 | 2021-2025 | |
| Aspira Women'S Health INC | $140.39 | 2021-2022 | |
| Axonics, INC. | $128.64 | 2022 | |
| Novo Nordisk INC | $121.60 | 2023 | Wegovy |
| Sumitomo Pharma America, INC. | $76.87 | 2023-2024 | Myfembree |
| Medtronic, INC. | $41.07 | 2023-2025 | Interstim |
| Pacira Pharmaceuticals Incorporated | $23.86 | 2023 | Exparel |
| Daiichi Sankyo INC. | $22.08 | 2021 | |
| Lilly USA, LLC | $17.14 | 2025 | Zepbound |
| Merck Sharp & Dohme LLC | $17.05 | 2021 | |
| Hologic Sales and Service, LLC | $14.38 | 2024 | Aptima |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.17 | 2021 | |
| Pfizer INC. | $13.10 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bonnie Simpson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.